Nathaniel Tillman, in Wesson, MS - Licensed Practical Nurse

Nathaniel Tillman, is a Licensed Practical Nurse based in Wesson, Mississippi. Nathaniel Tillman is licensed to practice in Mississippi (license number P318494) and his current practice location is 2124 John Smith Ln, Wesson, Mississippi. He can be reached at his office (for appointments etc.) via phone at (601) 754-4651.

NPI number for Nathaniel Tillman is 1417350323 and his current mailing address is 2124 John Smith Ln, Wesson, Mississippi. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1417350323.

Contact Information

	Nathaniel Tillman,
	2124 John Smith Ln, Wesson, MS 39191-7733
	(601) 754-4651
	Not Available

Provider's Profile

Full Name	Nathaniel Tillman
Gender	Male
Speciality	Licensed Practical Nurse
Location	2124 John Smith Ln, Wesson, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1417350323
Provider Enumeration Date: 10/06/2014
Last Update Date: 10/06/2014

Medical Identifiers

Medical identifiers for Nathaniel Tillman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417350323	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	P318494 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nathaniel Tillman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nathaniel Tillman, 2124 John Smith Ln, Wesson, MS 39191-7733 Ph: () -	Nathaniel Tillman, 2124 John Smith Ln, Wesson, MS 39191-7733 Ph: (601) 754-4651

News Archive

Reducing antibiotic prescribing in primary care alone may not stop drug-resistant E. coli infections

Strategies to reduce antibiotic prescribing in primary care are insufficient alone to halt the rise in drug resistant E. coli infections in England, a new report concludes.

Newly developed oxidation process uses ozone to degrade contaminants in water

At the Center for Research and Assistance in Technology and Design of the State of Jalisco (CIATEJ) at the east of Mexico, an oxidation process was developed that uses ozone to degrade contaminants in water that alter the synthesis, transport, action or elimination of natural hormones, responsible for maintain self-regulation of metabolic and reproductive processes in living beings.

Scientists develop "electronic skin" for earlier identification of breast cancer

For detecting cancer, manual breast exams seem low-tech compared to other methods such as MRI. But scientists are now developing an "electronic skin" that "feels" and images small lumps that fingers can miss.

Roche completes enrollment in RG7128 Phase 2b PROPEL study

Pharmasset, Inc. announced today the complete enrollment by Roche of the 12 week RG7128 Phase 2b study (PROPEL) of approximately 400 treatment-naive patients with hepatitis C virus (HCV) genotypes 1 and 4. The study remains blinded to Roche and Pharmasset.

Nathaniel Tillman, - Licensed Practical Nurse in Wesson, MS